Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

by International Association for the Study of Lung CancerLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA clinical trial testing the toxicity of a KRAS inhibitor demons

Updated on: March 14,2024 20

Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

by International Association for the Study of Lung CancerLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA clinical trial testing the toxicity of a KRAS inhibitor demons

Updated on:March 14,2024 20

Treatment advances and predictive biomarkers stand to improve bladder cancer care

byUniversity of North Carolina Health CareCredit: AI-generated imageRecent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk

Updated on: November 30,2024 0

Treatment advances and predictive biomarkers stand to improve bladder cancer care

byUniversity of North Carolina Health CareCredit: AI-generated imageRecent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk

Updated on:November 30,2024 0

Incidence of early-stage breast CA, CRC up with ACA adoption

(HealthDay)—After adoption of the Affordable Care Act (ACA), there was an increase in the incidence of early-stage breast and colorectal cancer, according to a research letter published online Nov. 2

Updated on: April 20,2024 12

Incidence of early-stage breast CA, CRC up with ACA adoption

(HealthDay)—After adoption of the Affordable Care Act (ACA), there was an increase in the incidence of early-stage breast and colorectal cancer, according to a research letter published online Nov. 2

Updated on:April 20,2024 12

Researchers investigate effects of pharmacological antioxidant compound DPDT on tumor cells

by Impact Journals LLCApoptosis induction by DPDT. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28465A new research paper has been published in the journalOncotargetentitled, &q

Updated on: February 18,2024 14

Researchers investigate effects of pharmacological antioxidant compound DPDT on tumor cells

by Impact Journals LLCApoptosis induction by DPDT. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28465A new research paper has been published in the journalOncotargetentitled, &q

Updated on:February 18,2024 14

Researchers identify protein linked to heart failure in chemo patients

by University of ManitobaCredit: CC0 Public DomainA team led by Dr. Lorrie Kirshenbaum from the Rady Faculty of Health Sciences and St. Boniface Hospital Research has identified a protein called

Updated on: January 30,2024 15

Researchers identify protein linked to heart failure in chemo patients

by University of ManitobaCredit: CC0 Public DomainA team led by Dr. Lorrie Kirshenbaum from the Rady Faculty of Health Sciences and St. Boniface Hospital Research has identified a protein called

Updated on:January 30,2024 15

Breast cancer survivors can safely interrupt therapy during pregnancy: study

by Amy NortonFor young women who survive breast cancer, a new study offers some reassurance about pregnancy: Pausing hormonal therapy to have a baby does not raise the risk of a cancer recurrence, at

Updated on: February 18,2024 14

Breast cancer survivors can safely interrupt therapy during pregnancy: study

by Amy NortonFor young women who survive breast cancer, a new study offers some reassurance about pregnancy: Pausing hormonal therapy to have a baby does not raise the risk of a cancer recurrence, at

Updated on:February 18,2024 14

Investigational personalized vaccine provides clinical benefit for some patients with resected head and neck cancers

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainTG4050, a personalized neoantigen vaccine, induced tumor-specific immune responses and led to low rates of disease rela

Updated on: April 28,2024 0

Investigational personalized vaccine provides clinical benefit for some patients with resected head and neck cancers

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainTG4050, a personalized neoantigen vaccine, induced tumor-specific immune responses and led to low rates of disease rela

Updated on:April 28,2024 0

Targeting LTA4H improves the tumor immune microenvironment in ovarian cancer: Study

by Science China PressKnockdown of LTA4H resulted in an attenuated tumor growth and ascites formation. Flow cytometry results showed significantly increased ratio of M1 to M2 macrophages and perc

Updated on: March 20,2024 18

Targeting LTA4H improves the tumor immune microenvironment in ovarian cancer: Study

by Science China PressKnockdown of LTA4H resulted in an attenuated tumor growth and ascites formation. Flow cytometry results showed significantly increased ratio of M1 to M2 macrophages and perc

Updated on:March 20,2024 18

Redefining colorectal cancer subtypes

by The City University of New YorkCredit: The City University of New YorkThere is a long-standing belief that colorectal cancer (CRC), which causes some 50,000 deaths in the United States each ye

Updated on: April 07,2024 11

Redefining colorectal cancer subtypes

by The City University of New YorkCredit: The City University of New YorkThere is a long-standing belief that colorectal cancer (CRC), which causes some 50,000 deaths in the United States each ye

Updated on:April 07,2024 11

New computational approach increases accessibility to single-cell tumor profiling to improve treatment outcomes

by Ana María Rodríguez, Ph.D.,Baylor College of MedicineCredit:Genome Biology(2023). DOI: 10.1186/s13059-023-03016-6To improve therapies for cancer and other diseases, researchers st

Updated on: January 12,2024 10

New computational approach increases accessibility to single-cell tumor profiling to improve treatment outcomes

by Ana María Rodríguez, Ph.D.,Baylor College of MedicineCredit:Genome Biology(2023). DOI: 10.1186/s13059-023-03016-6To improve therapies for cancer and other diseases, researchers st

Updated on:January 12,2024 10

Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

by Xia & He PublishingICI, immune checkpoint inhibitor. Credit: Jian-Hong Zhong, Liang Ma, Le Li, Zhen-Zhen LiHepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and

Updated on: July 17,2024 0

Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

by Xia & He PublishingICI, immune checkpoint inhibitor. Credit: Jian-Hong Zhong, Liang Ma, Le Li, Zhen-Zhen LiHepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and

Updated on:July 17,2024 0

New treatment for urinary tract cancer could prevent kidney dialysis, transplant

by Michelle Brubaker,University of California - San DiegoCredit: Pixabay/CC0 Public DomainUC San Diego Health is now offering a new treatment for patients with low-grade upper tract urothelial c

Updated on: January 02,2024 9

New treatment for urinary tract cancer could prevent kidney dialysis, transplant

by Michelle Brubaker,University of California - San DiegoCredit: Pixabay/CC0 Public DomainUC San Diego Health is now offering a new treatment for patients with low-grade upper tract urothelial c

Updated on:January 02,2024 9